PropertyValue
?:abstract
  • Gastrointestinal symptoms are common and frequently reported in Coronavirus Disease-2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is unclear if SARS-CoV-2 is associated with increased risk of gastrointestinal bleeding (GIB). Nevertheless, GIB in COVID-19 patients poses unique challenges to patients due to high-risk of concomitant respiratory failure and to endoscopy personnel due to risk of airborne transmission during endoscopic procedures. Many management issues related to COVID-19 are still being studied. In this case series, we attempt to discuss the important clinical implications related to the management of GIB in COVID-19 patients.
?:creator
?:doi
  • 10.14309/ajg.0000000000000719
?:doi
?:journal
  • Am_J_Gastroenterol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/6b3efa223376b9fda3beb2ba92fd98e27cc41416.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7302090.xml.json
?:pmcid
?:pmid
?:pmid
  • 32516204.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Gastrointestinal Bleeding in Patients with Severe SARS-CoV-2
?:type
?:year
  • 2020-06-04

Metadata

Anon_0  
expand all